Use of pde iii inhibitors or calcium sensitizers for the treatment of asymptomatic (occult) heart failure

Use of pde iii inhibitors or calcium sensitizers for the treatment of asymptomatic (occult) heart failure

  • CN 101,309,685 A
  • Filed: 11/08/2006
  • Published: 11/19/2008
  • Est. Priority Date: 11/14/2005
  • Status: Active Application
First Claim
Patent Images

1. phosphodiesterase iii type (PDE III) inhibitor or Ca 2+Sensitizer or its pharmaceutically useful derivant are used for reducing the heart size of suffering from asymptomatic (hiding property) heart failure patient in preparation, or are used for prolonging the purposes of trouble asymptomatic (hiding property) heart failure patient to the medicine of the time of clinical symptoms outbreak.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×